Researchers identify potential therapeutic target for ER-negative breast cancer

[News]

Using a new in vivo screening system, Whitehead Institute researchers have identified a protein in the serine biosynthesis pathway that is essential in estrogen receptor (ER)-negative breast cancer—a notoriously difficult disease to treat associated with low five-year survival rates.

More... (http://www.news-medical.net/news/20110719/Researchers-identify-potential-therapeutic-target-for-ER-negative-breast-cancer.aspx)